PMCCPMCCPMCC

Search tips
Search criteria 

Advanced
Logo of aacJournal InfoAuthorsReviewersSubscribersPermissionsJournals.ASM.orgJournalAAC ArticleJournal InfoAuthorsReviewers
 
Volume 50(4);  April 2006
Minireview
β-Lactamase Nomenclature
George A. Jacoby
Antimicrob Agents Chemother. 2006 April; 50(4): 1123–1129. doi: 10.1128/AAC.50.4.1123-1129.2006
PMCID:
PMC1426973
Full Text PDF–102K
Chemistry; Biosynthesis
Structure-Activity Relationships of Aminocoumarin-Type Gyrase and Topoisomerase IV Inhibitors Obtained by Combinatorial Biosynthesis
Ruth H. Flatman, Alessandra Eustaquio, Shu-Ming Li, Lutz Heide, Anthony Maxwell
Antimicrob Agents Chemother. 2006 April; 50(4): 1136–1142. doi: 10.1128/AAC.50.4.1136-1142.2006
PMCID:
PMC1426943
Abstract Full Text PDF–297K
Protease-Stable Polycationic Photosensitizer Conjugates between Polyethyleneimine and Chlorin(e6) for Broad-Spectrum Antimicrobial Photoinactivation
George P. Tegos, Masahiro Anbe, Changming Yang, Tatiana N. Demidova, Minahil Satti, Pawel Mroz, Sumbul Janjua, Faten Gad, Michael R. Hamblin
Antimicrob Agents Chemother. 2006 April; 50(4): 1402–1410. doi: 10.1128/AAC.50.4.1402-1410.2006
PMCID:
PMC1426948
Abstract Full Text PDF–197K
Mechanisms of Action: Physiological Effects
Bac 32, a Novel Bacteriocin Widely Disseminated among Clinical Isolates of Enterococcus faecium
Takako Inoue, Haruyoshi Tomita, Yasuyoshi Ike
Antimicrob Agents Chemother. 2006 April; 50(4): 1202–1212. doi: 10.1128/AAC.50.4.1202-1212.2006
PMCID:
PMC1426941
Abstract Full Text PDF–363K
Gentamicin Causes Apoptosis at Low Concentrations in Renal LLC-PK1 Cells Subjected to Electroporation
Hélène Servais, Yves Jossin, Françoise Van Bambeke, Paul M. Tulkens, Marie-Paule Mingeot-Leclercq
Antimicrob Agents Chemother. 2006 April; 50(4): 1213–1221. doi: 10.1128/AAC.50.4.1213-1221.2006
PMCID:
PMC1426926
Abstract Full Text PDF–329K
In Vitro Characterization of the Antibacterial Spectrum of Novel Bacterial Type II Topoisomerase Inhibitors of the Aminobenzimidazole Class
Nagraj Mani, Christian H. Gross, Jonathan D. Parsons, Brian Hanzelka, Ute Müh, Steve Mullin, Yusheng Liao, Anne-Laure Grillot, Dean Stamos, Paul S. Charifson, Trudy H. Grossman
Antimicrob Agents Chemother. 2006 April; 50(4): 1228–1237. doi: 10.1128/AAC.50.4.1228-1237.2006
PMCID:
PMC1426924
Abstract Full Text PDF–143K
Activity of Cecropin A-Melittin Hybrid Peptides against Colistin-Resistant Clinical Strains of Acinetobacter baumannii: Molecular Basis for the Differential Mechanisms of Action
José María Saugar, María Jesús Rodríguez-Hernández, Beatriz G. de la Torre, María Eugenia Pachón-Ibañez, María Fernández-Reyes, David Andreu, Jerónimo Pachón, Luis Rivas
Antimicrob Agents Chemother. 2006 April; 50(4): 1251–1256. doi: 10.1128/AAC.50.4.1251-1256.2006
PMCID:
PMC1426946
Abstract Full Text PDF–122K
Time Course of Microbiologic Outcome and Gene Expression in Candida albicans during and following In Vitro and In Vivo Exposure to Fluconazole
A. Lepak, J. Nett, L. Lincoln, K. Marchillo, D. Andes
Antimicrob Agents Chemother. 2006 April; 50(4): 1311–1319. doi: 10.1128/AAC.50.4.1311-1319.2006
PMCID:
PMC1426956
Abstract Full Text PDF–305K Supplementary Material
Screen for Inhibitors of the Coupled Transglycosylase-Transpeptidase of Peptidoglycan Biosynthesis in Escherichia coli
Vasanthi Ramachandran, B. Chandrakala, Vidya P. Kumar, Veeraraghavan Usha, Suresh M. Solapure, Sunita M. de Sousa
Antimicrob Agents Chemother. 2006 April; 50(4): 1425–1432. doi: 10.1128/AAC.50.4.1425-1432.2006
PMCID:
PMC1426922
Abstract Full Text PDF–215K
Insights into In Vivo Activities of Lantibiotics from Gallidermin and Epidermin Mode-of-Action Studies
Raquel Regina Bonelli, Tanja Schneider, Hans-Georg Sahl, Imke Wiedemann
Antimicrob Agents Chemother. 2006 April; 50(4): 1449–1457. doi: 10.1128/AAC.50.4.1449-1457.2006
PMCID:
PMC1426925
Abstract Full Text PDF–263K
Interaction of Pleuromutilin Derivatives with the Ribosomal Peptidyl Transferase Center
Katherine S. Long, Lykke H. Hansen, Lene Jakobsen, Birte Vester
Antimicrob Agents Chemother. 2006 April; 50(4): 1458–1462. doi: 10.1128/AAC.50.4.1458-1462.2006
PMCID:
PMC1426994
Abstract Full Text PDF–281K
Adding Selectivity to Antimicrobial Peptides: Rational Design of a Multidomain Peptide against Pseudomonas spp.
Randal Eckert, Fengxia Qi, Daniel K. Yarbrough, Jian He, Maxwell H. Anderson, Wenyuan Shi
Antimicrob Agents Chemother. 2006 April; 50(4): 1480–1488. doi: 10.1128/AAC.50.4.1480-1488.2006
PMCID:
PMC1426969
Abstract Full Text PDF–474K
Binding of Neomycin-Class Aminoglycoside Antibiotics to Mutant Ribosomes with Alterations in the A Site of 16S rRNA
Sven N. Hobbie, Peter Pfister, Christian Bruell, Peter Sander, Boris François, Eric Westhof, Erik C. Böttger
Antimicrob Agents Chemother. 2006 April; 50(4): 1489–1496. doi: 10.1128/AAC.50.4.1489-1496.2006
PMCID:
PMC1426975
Abstract Full Text PDF–496K
The Antimicrobial Peptide Polyphemusin Localizes to the Cytoplasm of Escherichia coli following Treatment
Jon-Paul S. Powers, Morgan M. Martin, Danika L. Goosney, Robert E. W. Hancock
Antimicrob Agents Chemother. 2006 April; 50(4): 1522–1524. doi: 10.1128/AAC.50.4.1522-1524.2006
PMCID:
PMC1426961
Abstract Full Text PDF–130K
Mechanisms of Resistance
Organization of Tn2610 Containing Two Transposition Modules
Akiko Takaya, Masato Watanabe, Tomoko Yamamoto
Antimicrob Agents Chemother. 2006 April; 50(4): 1143–1147. doi: 10.1128/AAC.50.4.1143-1147.2006
PMCID:
PMC1426972
Abstract Full Text PDF–192K
Overexpression of Candida albicans CDR1, CDR2, or MDR1 Does Not Produce Significant Changes in Echinocandin Susceptibility
K. Niimi, K. Maki, F. Ikeda, A. R. Holmes, E. Lamping, M. Niimi, B. C. Monk, R. D. Cannon
Antimicrob Agents Chemother. 2006 April; 50(4): 1148–1155. doi: 10.1128/AAC.50.4.1148-1155.2006
PMCID:
PMC1426986
Abstract Full Text PDF–413K Supplementary Material
Distribution of Florfenicol Resistance Genes fexA and cfr among Chloramphenicol-Resistant Staphylococcus Isolates
Corinna Kehrenberg, Stefan Schwarz
Antimicrob Agents Chemother. 2006 April; 50(4): 1156–1163. doi: 10.1128/AAC.50.4.1156-1163.2006
PMCID:
PMC1426988
Abstract Full Text PDF–202K
qnrB, Another Plasmid-Mediated Gene for Quinolone Resistance
George A. Jacoby, Kelley E. Walsh, Debra M. Mills, Victoria J. Walker, Herin Oh, Ari Robicsek, David C. Hooper
Antimicrob Agents Chemother. 2006 April; 50(4): 1178–1182. doi: 10.1128/AAC.50.4.1178-1182.2006
PMCID:
PMC1426915
Abstract Full Text PDF–173K
Staphylococcus aureus CcpA Affects Virulence Determinant Production and Antibiotic Resistance
Kati Seidl, Martin Stucki, Martin Ruegg, Christiane Goerke, Christiane Wolz, Llinos Harris, Brigitte Berger-Bächi, Markus Bischoff
Antimicrob Agents Chemother. 2006 April; 50(4): 1183–1194. doi: 10.1128/AAC.50.4.1183-1194.2006
PMCID:
PMC1426959
Abstract Full Text PDF–457K
Clinical and Economic Impact of Bacteremia with Extended- Spectrum-β-Lactamase-Producing Enterobacteriaceae
Mitchell J. Schwaber, Shiri Navon-Venezia, Keith S. Kaye, Ronen Ben-Ami, David Schwartz, Yehuda Carmeli
Antimicrob Agents Chemother. 2006 April; 50(4): 1257–1262. doi: 10.1128/AAC.50.4.1257-1262.2006
PMCID:
PMC1426954
Abstract Full Text PDF–70K
MepR, a Repressor of the Staphylococcus aureus MATE Family Multidrug Efflux Pump MepA, Is a Substrate-Responsive Regulatory Protein
Glenn W. Kaatz, Carmen E. DeMarco, Susan M. Seo
Antimicrob Agents Chemother. 2006 April; 50(4): 1276–1281. doi: 10.1128/AAC.50.4.1276-1281.2006
PMCID:
PMC1426934
Abstract Full Text PDF–185K
In Vitro Analysis of ISEcp1B-Mediated Mobilization of Naturally Occurring β-Lactamase Gene blaCTX-M of Kluyvera ascorbata
Marie-Frédérique Lartigue, Laurent Poirel, Daniel Aubert, Patrice Nordmann
Antimicrob Agents Chemother. 2006 April; 50(4): 1282–1286. doi: 10.1128/AAC.50.4.1282-1286.2006
PMCID:
PMC1426957
Abstract Full Text PDF–95K
Novel Carbapenem-Hydrolyzing Oxacillinase OXA-62 from Pandoraea pnomenusa
Ines Schneider, Anne Marie Queenan, Adolf Bauernfeind
Antimicrob Agents Chemother. 2006 April; 50(4): 1330–1335. doi: 10.1128/AAC.50.4.1330-1335.2006
PMCID:
PMC1426949
Abstract Full Text PDF–199K
Contribution of rpoB2 RNA Polymerase β Subunit Gene to Rifampin Resistance in Nocardia Species
Jun Ishikawa, Kazuhiro Chiba, Haruyo Kurita, Hiroyuki Satoh
Antimicrob Agents Chemother. 2006 April; 50(4): 1342–1346. doi: 10.1128/AAC.50.4.1342-1346.2006
PMCID:
PMC1426977
Abstract Full Text PDF–277K
Involvement of the MexXY-OprM Efflux System in Emergence of Cefepime Resistance in Clinical Strains of Pseudomonas aeruginosa
Didier Hocquet, Patrice Nordmann, Farid El Garch, Ludovic Cabanne, Patrick Plésiat
Antimicrob Agents Chemother. 2006 April; 50(4): 1347–1351. doi: 10.1128/AAC.50.4.1347-1351.2006
PMCID:
PMC1426951
Abstract Full Text PDF–75K
Overexpression of the MDR1 Gene Is Sufficient To Confer Increased Resistance to Toxic Compounds in Candida albicans
Davina Hiller, Dominique Sanglard, Joachim Morschhäuser
Antimicrob Agents Chemother. 2006 April; 50(4): 1365–1371. doi: 10.1128/AAC.50.4.1365-1371.2006
Correction in:
Antimicrob Agents Chemother. 2006 July; 50(7): 2591.
PMCID:
PMC1426927
Abstract Full Text PDF–307K Correction
Candida glabrata PDR1, a Transcriptional Regulator of a Pleiotropic Drug Resistance Network, Mediates Azole Resistance in Clinical Isolates and Petite Mutants
Huei-Fung Tsai, Anna A. Krol, Kelly E. Sarti, John E. Bennett
Antimicrob Agents Chemother. 2006 April; 50(4): 1384–1392. doi: 10.1128/AAC.50.4.1384-1392.2006
PMCID:
PMC1426987
Abstract Full Text PDF–270K
Comparative Analysis of Chromosome-Encoded Microcins
María Eloisa Poey, María F. Azpiroz, Magela Laviña
Antimicrob Agents Chemother. 2006 April; 50(4): 1411–1418. doi: 10.1128/AAC.50.4.1411-1418.2006
PMCID:
PMC1426990
Abstract Full Text PDF–229K
Genetic Structures at the Origin of Acquisition and Expression of the Carbapenem-Hydrolyzing Oxacillinase Gene blaOXA-58 in Acinetobacter baumannii
Laurent Poirel, Patrice Nordmann
Antimicrob Agents Chemother. 2006 April; 50(4): 1442–1448. doi: 10.1128/AAC.50.4.1442-1448.2006
PMCID:
PMC1426978
Abstract Full Text PDF–211K
In Vivo Selection of Fluoroquinolone-Resistant Escherichia coli Isolates Expressing Plasmid-Mediated Quinolone Resistance and Expanded-Spectrum β-Lactamase
Laurent Poirel, Johann D. D. Pitout, Lucy Calvo, Jose-Manuel Rodriguez-Martinez, Deirdre Church, Patrice Nordmann
Antimicrob Agents Chemother. 2006 April; 50(4): 1525–1527. doi: 10.1128/AAC.50.4.1525-1527.2006
PMCID:
PMC1426952
Abstract Full Text PDF–52K
Gatifloxacin Resistance and Mutations in gyrA after Unsuccessful Helicobacter pylori Eradication in Japan
Toshihiro Nishizawa, Hidekazu Suzuki, Kumiko Kurabayashi, Tatsuhiro Masaoka, Hiroe Muraoka, Mikiji Mori, Eisuke Iwasaki, Intetsu Kobayashi, Toshifumi Hibi
Antimicrob Agents Chemother. 2006 April; 50(4): 1538–1540. doi: 10.1128/AAC.50.4.1538-1540.2006
PMCID:
PMC1426923
Abstract Full Text PDF–48K
Autolytic Properties of Glycopeptide-Intermediate Staphylococcus aureus Mu50
Sugunya Utaida, Richard F. Pfeltz, R. K. Jayaswal, B. J. Wilkinson
Antimicrob Agents Chemother. 2006 April; 50(4): 1541–1545. doi: 10.1128/AAC.50.4.1541-1545.2006
PMCID:
PMC1426971
Abstract Full Text PDF–166K
Quadruple Mutations in Dihydrofolate Reductase of Plasmodium falciparum Isolates from Car Nicobar Island, India
Anwar Ahmed, Manoj K. Das, Vas Dev, Muheet A. Saifi, Wajihullah, Yagya D. Sharma
Antimicrob Agents Chemother. 2006 April; 50(4): 1546–1549. doi: 10.1128/AAC.50.4.1546-1549.2006
PMCID:
PMC1426982
Abstract Full Text PDF–115K
Genetic Basis of Tetracycline and Minocycline Resistance in Potentially Probiotic Lactobacillus plantarum Strain CCUG 43738
Geert Huys, Klaas D'Haene, Jean Swings
Antimicrob Agents Chemother. 2006 April; 50(4): 1550–1551. doi: 10.1128/AAC.50.4.1550-1551.2006
PMCID:
PMC1426919
Abstract Full Text PDF–44K
Prevalence of First-Step Mutants among Levofloxacin-Susceptible Invasive Isolates of Streptococcus pneumoniae in the United States
Mathias W. R. Pletz, Ardaman P. Shergill, Lesley McGee, Bernard Beall, Cynthia G. Whitney, Keith P. Klugman, for the Active Bacterial Core Surveillance Team
Antimicrob Agents Chemother. 2006 April; 50(4): 1561–1563. doi: 10.1128/AAC.50.4.1561-1563.2006
PMCID:
PMC1426940
Abstract Full Text PDF–134K
Induction of Daptomycin Heterogeneous Susceptibility in Staphylococcus aureus by Exposure to Vancomycin
George Sakoulas, Jeff Alder, Claudie Thauvin-Eliopoulos, Robert C. Moellering, Jr., George M. Eliopoulos
Antimicrob Agents Chemother. 2006 April; 50(4): 1581–1585. doi: 10.1128/AAC.50.4.1581-1585.2006
PMCID:
PMC1426932
Abstract Full Text PDF–312K
Variability in the Region Downstream of the blaCMY-2 β-Lactamase Gene in Escherichia coli and Salmonella enterica Plasmids
Min-Su Kang, Thomas E. Besser, Douglas R. Call
Antimicrob Agents Chemother. 2006 April; 50(4): 1590–1593. doi: 10.1128/AAC.50.4.1590-1593.2006
PMCID:
PMC1426964
Abstract Full Text PDF–127K
New Real-Time PCR Assay Using Locked Nucleic Acid Probes To Assess Prevalence of ParC Mutations in Fluoroquinolone-Susceptible Streptococcus pneumoniae Isolates from France
Jean-Winoc Decousser, Imen Methlouthi, Patrick Pina, Anne Collignon, Pierre Allouch, on behalf of the ColBVH Study Group
Antimicrob Agents Chemother. 2006 April; 50(4): 1594–1598. doi: 10.1128/AAC.50.4.1594-1598.2006
PMCID:
PMC1426917
Abstract Full Text PDF–122K
Large Conjugative Plasmids from Clinical Strains of Salmonella enterica Serovar Virchow Contain a Class 2 Integron in Addition to Class 1 Integrons and Several Non-Integron-Associated Drug Resistance Determinants
Irene Rodríguez, M. Rosario Rodicio, M. Carmen Mendoza, M. Cruz Martín
Antimicrob Agents Chemother. 2006 April; 50(4): 1603–1607. doi: 10.1128/AAC.50.4.1603-1607.2006
PMCID:
PMC1426967
Abstract Full Text PDF–199K
Susceptibility
Evaluation of Amphotericin B Interpretive Breakpoints for Candida Bloodstream Isolates by Correlation with Therapeutic Outcome
Benjamin J. Park, Beth A. Arthington-Skaggs, Rana A. Hajjeh, Naureen Iqbal, Meral A. Ciblak, Wendy Lee-Yang, Mario D. Hairston, Maureen Phelan, Brian D. Plikaytis, Andre N. Sofair, Lee H. Harrison, Scott K. Fridkin, David W. Warnock
Antimicrob Agents Chemother. 2006 April; 50(4): 1287–1292. doi: 10.1128/AAC.50.4.1287-1292.2006
PMCID:
PMC1426914
Abstract Full Text PDF–106K
Effect of Farnesol on Staphylococcus aureus Biofilm Formation and Antimicrobial Susceptibility
M. A. Jabra-Rizk, T. F. Meiller, C. E. James, M. E. Shirtliff
Antimicrob Agents Chemother. 2006 April; 50(4): 1463–1469. doi: 10.1128/AAC.50.4.1463-1469.2006
PMCID:
PMC1426993
Abstract Full Text PDF–412K
Plasmodium falciparum In Vitro Susceptibility to Antimalarial Drugs in Casamance (Southwestern Senegal) during the First 5 Years of Routine Use of Artesunate-Amodiaquine
P. Agnamey, P. Brasseur, P. Eldin de Pecoulas, Michel Vaillant, P. Olliaro
Antimicrob Agents Chemother. 2006 April; 50(4): 1531–1534. doi: 10.1128/AAC.50.4.1531-1534.2006
PMCID:
PMC1426962
Abstract Full Text PDF–128K
Antimalarial Activity of a Synthetic Endoperoxide (RBx-11160/OZ277) against Plasmodium falciparum Isolates from Gabon
Andrea Kreidenweiss, Benjamin Mordmüller, Sanjeev Krishna, Peter G. Kremsner
Antimicrob Agents Chemother. 2006 April; 50(4): 1535–1537. doi: 10.1128/AAC.50.4.1535-1537.2006
PMCID:
PMC1426938
Abstract Full Text PDF–45K
In Vitro Activity of Tigecycline against Burkholderia pseudomallei and Burkholderia thailandensis
Visanu Thamlikitkul, Suwanna Trakulsomboon
Antimicrob Agents Chemother. 2006 April; 50(4): 1555–1557. doi: 10.1128/AAC.50.4.1555-1557.2006
PMCID:
PMC1426953
Abstract Full Text PDF–49K
Immunotherapy with Tacrolimus (FK506) Does Not Select for Resistance to Calcineurin Inhibitors in Candida albicans Isolates from Liver Transplant Patients
Jennifer L. Reedy, Shahid Husain, Michael Ison, Timothy L. Pruett, Nina Singh, Joseph Heitman
Antimicrob Agents Chemother. 2006 April; 50(4): 1573–1577. doi: 10.1128/AAC.50.4.1573-1577.2006
PMCID:
PMC1426937
Abstract Full Text PDF–257K
Biologic Response Modifiers
Human β-Defensin 2 Induces a Vigorous Cytokine Response in Peripheral Blood Mononuclear Cells
Michele Boniotto, William J. Jordan, Joyce Eskdale, Alessandro Tossi, Nikolinka Antcheva, Sergio Crovella, Nancy D. Connell, Grant Gallagher
Antimicrob Agents Chemother. 2006 April; 50(4): 1433–1441. doi: 10.1128/AAC.50.4.1433-1441.2006
PMCID:
PMC1426918
Abstract Full Text PDF–651K
Antiviral Agents
Maribavir Pharmacokinetics and the Effects of Multiple-Dose Maribavir on Cytochrome P450 (CYP) 1A2, CYP 2C9, CYP 2C19, CYP 2D6, CYP 3A, N-Acetyltransferase-2, and Xanthine Oxidase Activities in Healthy Adults
Joseph D. Ma, Anne N. Nafziger, Stephen A. Villano, Andrea Gaedigk, Joseph S. Bertino, Jr.
Antimicrob Agents Chemother. 2006 April; 50(4): 1130–1135. doi: 10.1128/AAC.50.4.1130-1135.2006
PMCID:
PMC1426970
Abstract Full Text PDF–101K
Triaryl Pyrazoline Compound Inhibits Flavivirus RNA Replication
Francesc Puig-Basagoiti, Mark Tilgner, Brett M. Forshey, Sean M. Philpott, Noel G. Espina, David E. Wentworth, Scott J. Goebel, Paul S. Masters, Barry Falgout, Ping Ren, David M. Ferguson, Pei-Yong Shi
Antimicrob Agents Chemother. 2006 April; 50(4): 1320–1329. doi: 10.1128/AAC.50.4.1320-1329.2006
PMCID:
PMC1426921
Abstract Full Text PDF–427K
Activity and Mechanism of Action of N-Methanocarbathymidine against Herpesvirus and Orthopoxvirus Infections
Mark N. Prichard, Kathy A. Keith, Debra C. Quenelle, Earl R. Kern
Antimicrob Agents Chemother. 2006 April; 50(4): 1336–1341. doi: 10.1128/AAC.50.4.1336-1341.2006
PMCID:
PMC1426929
Abstract Full Text PDF–79K
Phosphorothioate Oligonucleotides Inhibit Human Immunodeficiency Virus Type 1 Fusion by Blocking gp41 Core Formation
Andrew Vaillant, Jean-Marc Juteau, Hong Lu, Shuwen Liu, Carol Lackman-Smith, Roger Ptak, Shibo Jiang
Antimicrob Agents Chemother. 2006 April; 50(4): 1393–1401. doi: 10.1128/AAC.50.4.1393-1401.2006
PMCID:
PMC1426958
Abstract Full Text PDF–276K
Efficacy of Hospital Germicides against Adenovirus 8, a Common Cause of Epidemic Keratoconjunctivitis in Health Care Facilities
William A. Rutala, Jeffrey E. Peacock, Maria F. Gergen, Mark D. Sobsey, David J. Weber
Antimicrob Agents Chemother. 2006 April; 50(4): 1419–1424. doi: 10.1128/AAC.50.4.1419-1424.2006
PMCID:
PMC1426955
Abstract Full Text PDF–95K
Sialidase Fusion Protein as a Novel Broad-Spectrum Inhibitor of Influenza Virus Infection
Michael P. Malakhov, Laura M. Aschenbrenner, Donald F. Smee, Miles K. Wandersee, Robert W. Sidwell, Larisa V. Gubareva, Vasiliy P. Mishin, Frederick G. Hayden, Do Hyong Kim, Alice Ing, Erin R. Campbell, Mang Yu, Fang Fang
Antimicrob Agents Chemother. 2006 April; 50(4): 1470–1479. doi: 10.1128/AAC.50.4.1470-1479.2006
PMCID:
PMC1426979
Abstract Full Text PDF–375K
Preclinical Evaluation of Synthetic −2 RANTES as a Candidate Vaginal Microbicide To Target CCR5
Tina M. Kish-Catalone, Wuyuan Lu, Robert C. Gallo, Anthony L. DeVico
Antimicrob Agents Chemother. 2006 April; 50(4): 1497–1509. doi: 10.1128/AAC.50.4.1497-1509.2006
PMCID:
PMC1426989
Abstract Full Text PDF–2.0M
Substrate Envelope and Drug Resistance: Crystal Structure of RO1 in Complex with Wild-Type Human Immunodeficiency Virus Type 1 Protease
Moses Prabu-Jeyabalan, Nancy M. King, Ellen A. Nalivaika, Gabrielle Heilek-Snyder, Nick Cammack, Celia A. Schiffer
Antimicrob Agents Chemother. 2006 April; 50(4): 1518–1521. doi: 10.1128/AAC.50.4.1518-1521.2006
PMCID:
PMC1426980
Abstract Full Text PDF–296K
Ether Lipid Ester Derivatives of Cidofovir Inhibit Polyomavirus BK Replication In Vitro
Parmjeet Randhawa, Noush Afarin Farasati, Ron Shapiro, Karl Y. Hostetler
Antimicrob Agents Chemother. 2006 April; 50(4): 1564–1566. doi: 10.1128/AAC.50.4.1564-1566.2006
PMCID:
PMC1426942
Abstract Full Text PDF–112K
Experimental Therapeutics
Real-Time Reverse Transcription-PCR Quantification of Cytokine mRNA Expression in Golden Syrian Hamster Infected with Leishmania infantum and Treated with a New Amphotericin B Formulation
S. Rama Iñiguez, M. A. Dea-Ayuela, J. A. Sanchez-Brunete, J. J. Torrado, J. M. Alunda, F. Bolas-Fernández
Antimicrob Agents Chemother. 2006 April; 50(4): 1195–1201. doi: 10.1128/AAC.50.4.1195-1201.2006
PMCID:
PMC1426985
Abstract Full Text PDF–176K
Nanodisk-Associated Amphotericin B Clears Leishmania major Cutaneous Infection in Susceptible BALB/c Mice
Keith G. Nelson, Jeanette V. Bishop, Robert O. Ryan, Richard Titus
Antimicrob Agents Chemother. 2006 April; 50(4): 1238–1244. doi: 10.1128/AAC.50.4.1238-1244.2006
PMCID:
PMC1426947
Abstract Full Text PDF–271K
Rapid Microbiologic and Pharmacologic Evaluation of Experimental Compounds against Mycobacterium tuberculosis
Veronica Gruppo, Christine M. Johnson, Karen S. Marietta, Hataichanok Scherman, Erin E. Zink, Dean C. Crick, Linda B. Adams, Ian M. Orme, Anne J. Lenaerts
Antimicrob Agents Chemother. 2006 April; 50(4): 1245–1250. doi: 10.1128/AAC.50.4.1245-1250.2006
PMCID:
PMC1426968
Abstract Full Text PDF–112K
Garenoxacin Treatment of Experimental Endocarditis Caused by Viridans Group Streptococci
Paloma Anguita-Alonso, Mark S. Rouse, Kerryl E. Piper, James M. Steckelberg, Robin Patel
Antimicrob Agents Chemother. 2006 April; 50(4): 1263–1267. doi: 10.1128/AAC.50.4.1263-1267.2006
PMCID:
PMC1426944
Abstract Full Text PDF–102K
Using Bacteriophages To Reduce Formation of Catheter-Associated Biofilms by Staphylococcus epidermidis
John J. Curtin, Rodney M. Donlan
Antimicrob Agents Chemother. 2006 April; 50(4): 1268–1275. doi: 10.1128/AAC.50.4.1268-1275.2006
PMCID:
PMC1426991
Abstract Full Text PDF–471K
Assessment of the Paradoxical Effect of Caspofungin in Therapy of Candidiasis
Karl V. Clemons, Marife Espiritu, Rachana Parmar, David A. Stevens
Antimicrob Agents Chemother. 2006 April; 50(4): 1293–1297. doi: 10.1128/AAC.50.4.1293-1297.2006
Correction in:
Antimicrob Agents Chemother. 2006 July; 50(7): 2593.
PMCID:
PMC1426960
Abstract Full Text PDF–116K Correction
Impact of Enterococcus faecalis on the Bactericidal Activities of Arbekacin, Daptomycin, Linezolid, and Tigecycline against Methicillin-Resistant Staphylococcus aureus in a Mixed-Pathogen Pharmacodynamic Model
Kerry L. LaPlante, Michael J. Rybak, Kimberly D. Leuthner, Judy N. Chin
Antimicrob Agents Chemother. 2006 April; 50(4): 1298–1303. doi: 10.1128/AAC.50.4.1298-1303.2006
PMCID:
PMC1426965
Abstract Full Text PDF–179K
Antitrypanosomal and Antileishmanial Activities of Flavonoids and Their Analogues: In Vitro, In Vivo, Structure-Activity Relationship, and Quantitative Structure-Activity Relationship Studies
Deniz Tasdemir, Marcel Kaiser, Reto Brun, Vanessa Yardley, Thomas J. Schmidt, Fatma Tosun, Peter Rüedi
Antimicrob Agents Chemother. 2006 April; 50(4): 1352–1364. doi: 10.1128/AAC.50.4.1352-1364.2006
PMCID:
PMC1426963
Abstract Full Text PDF–181K
Multidimensional Volumetric Imaging of Pulmonary Infiltrates for Measuring Therapeutic Response to Antifungal Therapy in Experimental Invasive Pulmonary Aspergillosis
Vidmantas Petraitis, Ruta Petraitiene, Jeffrey Solomon, Amy M. Kelaher, Heidi A. Murray, Christine Mya-San, Avi K. Bhandary, Tin Sein, Nilo A. Avila, Algidas Basevicius, John Bacher, Thomas J. Walsh
Antimicrob Agents Chemother. 2006 April; 50(4): 1510–1517. doi: 10.1128/AAC.50.4.1510-1517.2006
PMCID:
PMC1426931
Abstract Full Text PDF–555K
In Vivo Efficacy of Aerosolized Nanostructured Itraconazole Formulations for Prevention of Invasive Pulmonary Aspergillosis
Barbara J. Hoeben, David S. Burgess, Jason T. McConville, Laura K. Najvar, Robert L. Talbert, Jay I. Peters, Nathan P. Wiederhold, Bradi L. Frei, John R. Graybill, Rosie Bocanegra, Kirk A. Overhoff, Prapasri Sinswat, Keith P. Johnston, Robert O. Williams, III
Antimicrob Agents Chemother. 2006 April; 50(4): 1552–1554. doi: 10.1128/AAC.50.4.1552-1554.2006
PMCID:
PMC1426984
Abstract Full Text PDF–82K
Bactericidal Activities of R207910 and Other Newer Antimicrobial Agents against Mycobacterium leprae in Mice
Baohong Ji, Aurélie Chauffour, Koen Andries, Vincent Jarlier
Antimicrob Agents Chemother. 2006 April; 50(4): 1558–1560. doi: 10.1128/AAC.50.4.1558-1560.2006
PMCID:
PMC1426933
Abstract Full Text PDF–47K
Sequential or Combination Antifungal Therapy with Voriconazole and Liposomal Amphotericin B in a Guinea Pig Model of Invasive Aspergillosis
William R. Kirkpatrick, Brent J. Coco, Thomas F. Patterson
Antimicrob Agents Chemother. 2006 April; 50(4): 1567–1569. doi: 10.1128/AAC.50.4.1567-1569.2006
PMCID:
PMC1426916
Abstract Full Text PDF–54K
Clinical Therapeutics
Comparing Gatifloxacin and Clarithromycin in Pneumonia Symptom Resolution and Process of Care
Nathan C. Dean, Paul Sperry, Matthew Wikler, Mary S. Suchyta, Carol Hadlock
Antimicrob Agents Chemother. 2006 April; 50(4): 1164–1169. doi: 10.1128/AAC.50.4.1164-1169.2006
PMCID:
PMC1426950
Abstract Full Text PDF–253K
Determinants of Rifampin, Isoniazid, Pyrazinamide, and Ethambutol Pharmacokinetics in a Cohort of Tuberculosis Patients
Helen McIlleron, Peter Wash, André Burger, Jennifer Norman, Peter I. Folb, Pete Smith
Antimicrob Agents Chemother. 2006 April; 50(4): 1170–1177. doi: 10.1128/AAC.50.4.1170-1177.2006
PMCID:
PMC1426981
Abstract Full Text PDF–89K
Microflora Changes with Norfloxacin and Pivmecillinam in Women with Recurrent Urinary Tract Infection
Birgit Stattin Norinder, Ragnar Norrby, Ann-Chatrin Palmgren, Sofia Hollenberg, Ulla Eriksson, Carl Erik Nord
Antimicrob Agents Chemother. 2006 April; 50(4): 1528–1530. doi: 10.1128/AAC.50.4.1528-1530.2006
PMCID:
PMC1426930
Abstract Full Text PDF–63K
Ritonavir Increases Plasma Amprenavir (APV) Exposure to a Similar Extent when Coadministered with either Fosamprenavir or APV
Mary B. Wire, Katherine L. Baker, Lori S. Jones, Mark J. Shelton, Yu Lou, Greg J. Thomas, M. Michelle Berrey
Antimicrob Agents Chemother. 2006 April; 50(4): 1578–1580. doi: 10.1128/AAC.50.4.1578-1580.2006
PMCID:
PMC1426966
Abstract Full Text PDF–66K
Good Clinical Outcomes but High Rates of Adverse Reactions during Linezolid Therapy for Serious Infections: a Proposed Protocol for Monitoring Therapy in Complex Patients
Emma Bishop, Sharmila Melvani, Benjamin P. Howden, Patrick G. P. Charles, M. Lindsay Grayson
Antimicrob Agents Chemother. 2006 April; 50(4): 1599–1602. doi: 10.1128/AAC.50.4.1599-1602.2006
PMCID:
PMC1426936
Abstract Full Text PDF–48K
Pharmacology
Comparative Pharmacokinetics and Pharmacodynamic Target Attainment of Ertapenem in Normal-Weight, Obese, and Extremely Obese Adults
M. Chen, A. N. Nafziger, G. L. Drusano, L. Ma, J. S. Bertino, Jr.
Antimicrob Agents Chemother. 2006 April; 50(4): 1222–1227. doi: 10.1128/AAC.50.4.1222-1227.2006
PMCID:
PMC1426983
Abstract Full Text PDF–108K
Pharmacokinetics of Tenofovir Disoproxil Fumarate and Ritonavir-Boosted Saquinavir Mesylate Administered Alone or in Combination at Steady State
Gregory E. Chittick, Jian Zong, M. Robert Blum, Jeffrey J. Sorbel, John A. Begley, Nathalie Adda, Brian P. Kearney
Antimicrob Agents Chemother. 2006 April; 50(4): 1304–1310. doi: 10.1128/AAC.50.4.1304-1310.2006
PMCID:
PMC1426992
Abstract Full Text PDF–92K
Impaired Target Site Penetration of Vancomycin in Diabetic Patients following Cardiac Surgery
Keso Skhirtladze, Doris Hutschala, Tatjana Fleck, Florian Thalhammer, Marek Ehrlich, Thomas Vukovich, Markus Müller, Edda M. Tschernko
Antimicrob Agents Chemother. 2006 April; 50(4): 1372–1375. doi: 10.1128/AAC.50.4.1372-1375.2006
PMCID:
PMC1426928
Abstract Full Text PDF–70K
Voriconazole Therapeutic Drug Monitoring
J. Smith, N. Safdar, V. Knasinski, W. Simmons, S. M. Bhavnani, P. G. Ambrose, D. Andes
Antimicrob Agents Chemother. 2006 April; 50(4): 1570–1572. doi: 10.1128/AAC.50.4.1570-1572.2006
PMCID:
PMC1426935
Abstract Full Text PDF–46K
New Approach for High-Throughput Screening of Drug Activity on Plasmodium Liver Stages
Audrey Gego, Olivier Silvie, Jean-François Franetich, Khemaïs Farhati, Laurent Hannoun, Adrian J. F. Luty, Robert W. Sauerwein, Claude Boucheix, Eric Rubinstein, Dominique Mazier
Antimicrob Agents Chemother. 2006 April; 50(4): 1586–1589. doi: 10.1128/AAC.50.4.1586-1589.2006
PMCID:
PMC1426939
Abstract Full Text PDF–122K
Letters to the Editor
First Report of Extended-Spectrum-ß-Lactamase-Producing Salmonella enterica Isolates in Ireland
Dearbhaile Morris, Mary Whelan, Geraldine Corbett-Feeney, Martin Cormican, Peter Hawkey, Xu Li, Geraldine Doran
Antimicrob Agents Chemother. 2006 April; 50(4): 1608–1609. doi: 10.1128/AAC.50.4.1608-1609.2006
PMCID:
PMC1426976
Full Text PDF–40K
First Isolation of blaIMI-2 in an Enterobacter cloacae Clinical Isolate from China
Yun-Song Yu, Xiao-Xing Du, Zhi-Hui Zhou, Ya-Gang Chen, Lan-Juan Li
Antimicrob Agents Chemother. 2006 April; 50(4): 1610–1611. doi: 10.1128/AAC.50.4.1610-1611.2006
PMCID:
PMC1426974
Full Text PDF–40K
Class 1 Integrons in Salmonella Strains Causing Traveler's Diarrhea
Roberto Cabrera, Francesc Marco, Jordi Vila, Joaquím Ruiz, Joaquím Gascón
Antimicrob Agents Chemother. 2006 April; 50(4): 1612–1613. doi: 10.1128/AAC.50.4.1612-1613.2006
PMCID:
PMC1426920
Full Text PDF–62K
Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of
American Society for Microbiology (ASM)